Amylin
Pancreas hormone released with insulin
Amylin is a hormone produced by the pancreas and released together with insulin after a meal. It slows stomach emptying and contributes to feelings of fullness. Synthetic forms of amylin have been studied in metabolic research.
Used in 4 research peptides
- MetabolicCagrilintideAmylin analog co-developed with semaglutide as 'CagriSema' for next-gen weight loss.
- MetabolicExenatideFirst-in-class GLP-1 mimetic derived from Gila monster venom; sold as Byetta/Bydureon.
- MetabolicRetatrutide + Cagrilintide StackInvestigational community stack pairing a triple incretin agonist with a long-acting amylin analog.
- MetabolicCagriSema (Cagrilintide + Semaglutide)Investigational once-weekly fixed combination of the amylin analog cagrilintide and the GLP-1 agonist semaglutide, studied in the Phase 3 REDEFINE program for weight management.
See also
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.